Bacterial Vaginosis and Behavioral Factors Associated With Incident Pelvic Inflammatory Disease in the Longitudinal Study of Vaginal Flora.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
16 08 2021
Historique:
entrez: 16 8 2021
pubmed: 17 8 2021
medline: 5 2 2022
Statut: ppublish

Résumé

Pelvic inflammatory disease (PID) leads to long-term reproductive consequences for cisgender women. Bacterial vaginosis (BV) and behavioral factors may play a role in PID pathogenesis. We assessed associations between BV, behavioral factors, and incident PID. We analyzed participants (N = 2956) enrolled in the National Institutes of Health Longitudinal Study of Vaginal Flora, a cohort of nonpregnant cisgender women followed quarterly for 12 months. PID was defined by at least 1 of the following: cervical motion tenderness, uterine tenderness, or adnexal tenderness (160 cases). We tested associations between BV (measured using Nugent and Amsel criteria) and PID at the subsequent visit. Sociodemographic factors, sexual behaviors, and Chlamydia trachomatis (CT), untreated at baseline and concurrent with BV, were covariates in Cox proportional hazards models. Adjusting for the few Neisseria gonorrhoeae and Trichomonas vaginalis cases did not alter results. In multivariable modeling, Nugent-BV (adjusted hazard ratio [aHR], 1.53 [95% confidence interval {CI}, 1.05-2.21]), symptomatic Amsel-BV (aHR, 2.15 [95% CI, 1.23-3.75]), and vaginal douching (aHR, 1.47 [95% CI, 1.03-2.09]) were associated with incident PID. BV was associated with incident PID in a large prospective cohort, controlling for behavioral factors and sexually transmitted infections (STIs). Larger studies on how BV, STIs, behaviors, and host responses interactively affect PID risk are needed.

Sections du résumé

BACKGROUND
Pelvic inflammatory disease (PID) leads to long-term reproductive consequences for cisgender women. Bacterial vaginosis (BV) and behavioral factors may play a role in PID pathogenesis. We assessed associations between BV, behavioral factors, and incident PID.
METHODS
We analyzed participants (N = 2956) enrolled in the National Institutes of Health Longitudinal Study of Vaginal Flora, a cohort of nonpregnant cisgender women followed quarterly for 12 months. PID was defined by at least 1 of the following: cervical motion tenderness, uterine tenderness, or adnexal tenderness (160 cases). We tested associations between BV (measured using Nugent and Amsel criteria) and PID at the subsequent visit. Sociodemographic factors, sexual behaviors, and Chlamydia trachomatis (CT), untreated at baseline and concurrent with BV, were covariates in Cox proportional hazards models. Adjusting for the few Neisseria gonorrhoeae and Trichomonas vaginalis cases did not alter results.
RESULTS
In multivariable modeling, Nugent-BV (adjusted hazard ratio [aHR], 1.53 [95% confidence interval {CI}, 1.05-2.21]), symptomatic Amsel-BV (aHR, 2.15 [95% CI, 1.23-3.75]), and vaginal douching (aHR, 1.47 [95% CI, 1.03-2.09]) were associated with incident PID.
CONCLUSIONS
BV was associated with incident PID in a large prospective cohort, controlling for behavioral factors and sexually transmitted infections (STIs). Larger studies on how BV, STIs, behaviors, and host responses interactively affect PID risk are needed.

Identifiants

pubmed: 34396403
pii: 6352155
doi: 10.1093/infdis/jiab103
pmc: PMC8499701
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

S137-S144

Subventions

Organisme : NIAID NIH HHS
ID : K23 AI125715
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI116799
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI119012
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 HD002535
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

Am J Obstet Gynecol. 2001 Apr;184(5):856-63; discussion 863-4
pubmed: 11303192
Sex Transm Infect. 2020 Sep;96(6):439-444
pubmed: 31810995
Expert Rev Anti Infect Ther. 2011 Jan;9(1):61-70
pubmed: 21171878
Am J Obstet Gynecol. 1988 Apr;158(4):819-28
pubmed: 3259075
AIDS Res Hum Retroviruses. 2019 Mar;35(3):219-228
pubmed: 30638028
Sex Transm Infect. 2019 Jun;95(4):300-306
pubmed: 30606817
J Infect Dis. 2016 Aug 15;214(4):617-24
pubmed: 27260786
Sex Transm Infect. 2016 Sep;92(6):441-6
pubmed: 26825087
Am J Prev Med. 2008 Jun;34(6):471-7
pubmed: 18471582
Clin Infect Dis. 2004 Oct 1;39(7):990-5
pubmed: 15472851
Infect Dis Obstet Gynecol. 2011;2011:959816
pubmed: 22235165
Am J Obstet Gynecol. 1994 Apr;170(4):1008-14; discussion 1014-7
pubmed: 8166184
Sex Transm Dis. 2018 Nov;45(11):770-773
pubmed: 29870505
J Clin Invest. 2011 Dec;121(12):4610-7
pubmed: 22133886
J Pediatr Adolesc Gynecol. 2007 Aug;20(4):225-31
pubmed: 17673134
MMWR Morb Mortal Wkly Rep. 2017 Jan 27;66(3):80-83
pubmed: 28125569
J Infect Dis. 2006 Jun 1;193(11):1478-86
pubmed: 16652274
Sci Transl Med. 2012 May 2;4(132):132ra52
pubmed: 22553250
Trop Doct. 2019 Apr;49(2):101-104
pubmed: 30755106
Am J Epidemiol. 2005 Sep 15;162(6):585-90
pubmed: 16093289
J Infect Dis. 2010 Dec 15;202(12):1907-15
pubmed: 21067371
Sex Transm Dis. 2014 Nov;41(11):665-70
pubmed: 25299413
Sex Transm Dis. 2013 Feb;40(2):117-22
pubmed: 23324974
N Engl J Med. 2020 May 14;382(20):1906-1915
pubmed: 32402161
MMWR Recomm Rep. 1998 Jan 23;47(RR-1):1-111
pubmed: 9461053
Clin Infect Dis. 2018 Jan 18;66(3):437-443
pubmed: 29136127
Sex Transm Dis. 2005 Jul;32(7):400-5
pubmed: 15976596
J Clin Microbiol. 1991 Feb;29(2):297-301
pubmed: 1706728
Clin Infect Dis. 2017 Jan 1;64(1):24-31
pubmed: 27567124
J Infect Dis. 2004 Dec 15;190(12):2109-20
pubmed: 15551209
Am J Obstet Gynecol. 1996 Aug;175(2):435-41
pubmed: 8765265
Obstet Gynecol. 2004 Oct;104(4):761-9
pubmed: 15458899
Clin Infect Dis. 2015 Dec 15;61 Suppl 8:S759-62
pubmed: 26602614
Am J Obstet Gynecol. 2003 Feb;188(2):318-23
pubmed: 12592233
Obstet Gynecol. 2004 Aug;104(2):267-72
pubmed: 15291998
Clin Microbiol Infect. 2019 Jan;25(1):35-47
pubmed: 29729331
Contraception. 2015 Aug;92(2):108-15
pubmed: 25592078
Clin Infect Dis. 2019 Oct 15;69(9):1517-1525
pubmed: 31504315
Obstet Gynecol. 1995 Mar;85(3):387-90
pubmed: 7862377
Ann Ist Super Sanita. 2019 Jul-Sep;55(3):217-223
pubmed: 31553313
Am J Obstet Gynecol. 1997 Nov;177(5):1184-7
pubmed: 9396917
Am J Obstet Gynecol. 2021 Mar;224(3):251-257
pubmed: 33091407
Sex Transm Dis. 2019 Jul;46(7):446-451
pubmed: 31194716
Br J Obstet Gynaecol. 1987 May;94(5):454-60
pubmed: 3580330
Am J Obstet Gynecol. 2006 Dec;195(6):1611-6
pubmed: 16769017
Am J Epidemiol. 2005 Jan 15;161(2):186-95
pubmed: 15632269
JAMA. 1990 Apr 11;263(14):1936-41
pubmed: 2313870
Clin Infect Dis. 2018 Aug 1;67(4):593-599
pubmed: 29420716
Am J Med. 1983 Jan;74(1):14-22
pubmed: 6600371

Auteurs

Rodman Turpin (R)

Department of Epidemiology and Biostatistics, School of Public Health, University of Maryland at College Park, College Park, Maryland, USA.

Susan Tuddenham (S)

Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Xin He (X)

Department of Epidemiology and Biostatistics, School of Public Health, University of Maryland at College Park, College Park, Maryland, USA.

Mark A Klebanoff (MA)

Center for Perinatal Research, Nationwide Children's Hospital, Columbus, Ohio, USA.

Khalil G Ghanem (KG)

Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Rebecca M Brotman (RM)

Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Institute for Genome Sciences, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH